Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state
Author:
Silvia Buonamici,Emanuela Ottaviani,Nicoletta Testoni,Vittorio Montefusco,Giuseppe Visani,Francesca Bonifazi,Marilina Amabile,Carolina Terragna,Deborah Ruggeri,Pier Paolo Piccaluga,Alessandro Isidori,Michele Malagola,Michele Baccarani,Sante Tura et al.
Copyright © 2002 American Society of Hematology